Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Mitomycin for intravesical solution showed a 24-month DOR of 72.2% in patients with LG-IR-NMIBC who achieved a complete response at 3 months. The ENVISION trial reported a 78% complete response rate ...

INKmune effectively primes resting NK cells into tumor-killing memory-like NK cells, showing a favorable safety profile across all dose levels in mCRPC patients. The trial demonstrated significant ...

Casdatifan showed promising clinical activity in clear cell RCC, with response rates between 25% and 33% across dosage cohorts. The 100 mg/day dosage of casdatifan is planned for future combination ...

ATNM-400 targets a non-PSMA protein, directly impacting tumor progression and resistance to ARPI therapy in prostate cancer models. Demonstrated improved survival and tumor control compared with ...

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

The findings highlight a lack of awareness on the signs and symptoms of prostate cancer, as well as common misconceptions about testicular cancer.

Data from the SunRISe-1 trial showed a complete response rate of 82%, with 51% of patients remaining in complete response for at least 1 year.

In the third article of the series, Melanie McGilloway, NP-C, an advanced practice provider at Genesis Urology in San Diego, discusses the various formulations of leuprolide, a gonadotropin-releasing ...

Millennial urologists appear to have developed strong opinions on health policy as reflected by their recent social media activity, observes urologist Alan L. Kaplan, MD.

Nivolumab plus ipilimumab improved overall survival and response rates over sunitinib in advanced renal cell carcinoma, with a median follow-up of 9.3 years. The combination showed sustained benefits ...

In a retrospective study of almost 500 men, the use of hyaluronic acid filler for penile girth enhancement appeared safe with limited adverse events. Using the PhalloFILL system, a novel hyaluronic ...